Telo Genomics Corp. (TDSGF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -33.11 Thousand CAD | 41.86% |
| 2022 | -56.95 Thousand CAD | 8.47% |
| 2021 | -62.22 Thousand CAD | 3.85% |
| 2020 | -64.71 Thousand CAD | 21.94% |
| 2019 | -82.9 Thousand CAD | 33.31% |
| 2018 | -124.32 Thousand CAD | -12.66% |
| 2017 | -110.35 Thousand CAD | -48.96% |
| 2016 | -74.08 Thousand CAD | -3074.29% |
| 2015 | -2334.00 CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | -9869.00 CAD | 6.4% |
| 2024 Q1 | -10.31 Thousand CAD | -1.32% |
| 2024 Q2 | -10.54 Thousand CAD | -2.26% |
| 2023 Q1 | -6154.00 CAD | 43.42% |
| 2023 FY | -33.11 Thousand CAD | 41.86% |
| 2023 Q2 | -7779.00 CAD | -26.41% |
| 2023 Q3 | -9004.00 CAD | -15.75% |
| 2023 Q4 | -10.17 Thousand CAD | -13.03% |
| 2022 Q2 | -16.11 Thousand CAD | -0.82% |
| 2022 Q1 | -15.98 Thousand CAD | -3.0% |
| 2022 FY | -56.95 Thousand CAD | 8.47% |
| 2022 Q4 | -10.87 Thousand CAD | 22.21% |
| 2022 Q3 | -13.98 Thousand CAD | 13.24% |
| 2021 FY | -62.22 Thousand CAD | 3.85% |
| 2021 Q3 | -15.67 Thousand CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | -15.51 Thousand CAD | 0.99% |
| 2020 FY | -64.71 Thousand CAD | 21.94% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 FY | -82.9 Thousand CAD | 33.31% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | -124.32 Thousand CAD | -12.66% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 FY | -110.35 Thousand CAD | -48.96% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 100.0% |
| 2016 Q1 | -64.01 Thousand CAD | -2642.54% |
| 2016 FY | -74.08 Thousand CAD | -3074.29% |
| 2016 Q4 | - CAD | 0.0% |
| 2015 FY | -2334.00 CAD | 0.0% |
| 2015 Q4 | -2334.00 CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 82.842% |
| Arrayit Corporation | 2.57 Million USD | 101.286% |
| Atlantic International Corp. | -154.23 Thousand USD | 78.53% |
| Biocept, Inc. | -2.58 Million USD | 98.718% |
| Bioqual, Inc. | 7.42 Million USD | 100.446% |
| CardioGenics Holdings Inc | - USD | Infinity% |
| DermTech, Inc. | 276 Thousand USD | 111.998% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 101.846% |
| iMD Companies, Inc. | -23.63 Thousand USD | -40.094% |
| IDenta Corp. | 662.97 Thousand USD | 104.995% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 100.144% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 142.689% |
| InVitro International | 635.98 Thousand USD | 105.207% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 100.505% |
| Many Bright Ideas Technologies Inc. | - USD | Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 103.031% |
| NovelStem International Corp. | 12 Thousand USD | 375.95% |
| Optigenex Inc. | -102.96 Thousand USD | 67.84% |
| PharmChem, Inc. | 3.9 Million USD | 100.848% |
| Proteome Sciences plc | 2.09 Million USD | 101.579% |
| Response Genetics, Inc | 3.94 Million USD | 100.84% |
| Rennova Health, Inc. | 6.26 Million USD | 100.528% |
| RushNet, Inc. | 1.1 Million USD | 102.998% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 103.866% |
| Stella Diagnostics Inc. | - USD | Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 91.798% |
| Todos Medical Ltd. | 4.31 Million USD | 100.768% |